Affiliation:
1. Department of Pharmaceutical Sciences, Dibrugarh University
2. Girijananda Chowdhury Institute of Pharmaceutical sciences, Guwahati
Abstract
A prominent class of broad-spectrum antibiotics known as tetracycline works by inhibiting the synthesis of proteins, which prevents the development of bacteria. Tetracycline resistance is typically attributed to one or more of the following causes: ribosomal binding site mutations, acquisition of mobile genetic elements carrying tetracycline-specific resistance genes, and/or chromosomal mutations that increase the expression of intrinsic resistance mechanisms. In this research, our objective is to virtually plan and conduct in-silico experiments to find tetracycline derivatives with inhibitory capability against tetracycline resistance protein. The tetracycline derivatives were screened using the Data Warrior, Discovery Studio, PyRx, and Swiss ADME web tools. Initially, 19 tetracycline derivatives were primarily screened for ADME and toxicity study followed by docking study. Among the tetracycline derivatives, C1, C11, C12, C14, C16, and C17 were found to be the potential drug-like molecules with binding energies of -8.9 kcal/mol, -8.4 kcal/mol, -8.5 kcal/mol, -7.7 kcal/mol, -7.7 kcal/mol, -8.6 kcal/mol respectively. In particular, C1 was predicted to have a better binding affinity towards the target protein than the others.
Reference14 articles.
1. Tanveer S, Masood AA, Ashiq K, Qayyum M, Bajwa MA, Rukh AS, Arshad A, Sattar R (2020). A Review on Existing Tetracyclines Analogues and Their Pharmacologically Targeted SAR. RADS J Pharm Pharm Sci. 8(3):1-8.
2. Neu HC (1992). The crisis in antibiotic resistance. Science http://doi.org/10.1126/science.257.5073.1064.
3. Etebu, E, Arikekpar I (2016). Antibiotics: Classification and mechanisms of action with emphasis on molecular perspectives. Int J Appl Microbiol Biotechnol Res, 4, 90-101.
4. Surabhi, Singh BK (2018). Computer aided drug design: an overview. Journal of Drug Delivery & Therapeutics. https://doi.org/10.22270/jddt.v8i5.1894
5. Gaba M, Gaba P, Singh S, Gupta G (2010). An overview on molecular docking, International Journal of Drug Development & Research. 2(2):219-231.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献